Maintaining Blood Glucose Levels in Range (70-150 mg/dL) is Difficult in COVID-19 Compared to Non-COVID-19 ICU Patients-A Retrospective Analysis.

Maintaining Blood Glucose Levels in Range (70-150 mg/dL) is Difficult in COVID-19 Compared to Non-COVID-19 ICU Patients-A Retrospective Analysis.
复制标题

DOI:
10.3390/jcm9113635
复制
发表时间:
2020-11-12
影响因子:
3.9
通讯作者:
Rahman O
Rahman O
中科院分区:
医学2区
文献类型:
--
作者:
Kapoor R;Timsina LR;Gupta N;Kaur H;Vidger AJ;Pollander AM;Jacobi J;Khare S;Rahman O

文献摘要

参考文献

被引文献

相似文献

建议 COVID-19 感染患者出现 β 细胞功能障碍。 ICU 血糖控制不良与患者预后不良相关。这是对 2020 年 3 月 1 日至 4 月 30 日重症监护病房的 562 名患者进行的单中心回顾性分析。我们回顾了重症 COVID-19 患者和非 COVID-19 患者的时间范围 (70–150 mg/dL),以及每日胰岛素使用情况。对 COVID-19 队列中的 93 名受试者和非 COVID-19 队列中的 469 名受试者进行了血糖 TIR (70–150 mg/dL) 百分比和平均每日胰岛素使用量的比较。与非 COVID-19 队列相比,COVID-19 队列花费的 TIR 显着减少(70-150 mg/dL)(44.4% vs. 68.5%)。 COVID-19 队列中每日平均胰岛素使用量较高(8.37 单位 vs 6.17 单位)。 ICU COVID-19 患者在范围 (70–150 mg/dL) 内花费的时间较短,并且需要较高的每日胰岛素剂量。对呼吸机的要求和呼吸机使用天数越高,TIR 越低。 TIR 较高的 COVID-19 患者死亡率较低。
Beta cell dysfunction is suggested in patients with COVID-19 infections. Poor glycemic control in ICU is associated with poor patient outcomes. This is a single center, retrospective analysis of 562 patients in an intensive care unit from 1 March to 30 April 2020. We review the time in range (70–150 mg/dL) spent by critically ill COVID-19 patients and non-COVID-19 patients, along with the daily insulin use. Ninety-three in the COVID-19 cohort and 469 in the non-COVID-19 cohort were compared for percentage of blood glucose TIR (70–150 mg/dL) and average daily insulin use. The COVID-19 cohort spent significantly less TIR (70–150 mg/dL) compared to the non-COVID-19 cohort (44.4% vs. 68.5%). Daily average insulin use in the COVID-19 cohort was higher (8.37 units versus 6.17 units). ICU COVID-19 patients spent less time in range (70–150 mg/dL) and required higher daily insulin dose. A higher requirement for ventilator and days on ventilator was associated with a lower TIR. Mortality was lower for COVID-19 patients who achieved a higher TIR.
DOI: 10.1038/nm1267
发表时间: 2005-08
期刊: Nature medicine
影响因子: 82.9
作者:
Kuba K;Imai Y;Rao S;Gao H;Guo F;Guan B;Huan Y;Yang P;Zhang Y;Deng W;Bao L;Zhang B;Liu G;Wang Z;Chappell M;Liu Y;Zheng D;Leibbrandt A;Wada T;Slutsky AS;Liu D;Qin C;Jiang C;Penninger JM
通讯作者: Penninger JM
DOI: 10.1002/path.1570
发表时间: 2004-06-01
影响因子: 7.3
作者:
Hamming, I;Timens, W;van Goor, H
通讯作者: van Goor, H
DOI: 10.4065/78.12.1471
发表时间: 2003-12-01
影响因子: 8.9
作者:
Krinsley, JS
通讯作者: Krinsley, JS
DOI: 10.1007/s00134-003-1961-2
发表时间: 2003-12-01
影响因子: 38.9
作者:
Philips, BJ;Meguer, JX;Baker, EH
通讯作者: Baker, EH
DOI: 10.1210/jc.87.1.144
发表时间: 2002-01-01
影响因子: 5.8
作者:
Hrebícek, J;Janout, V;Cízek, L
通讯作者: Cízek, L